And the overall protein level of MRC2 is significantly higher in the breast cancers compared with normal tissues among the human samples collected in the Clinical Proteomic Tumor Analysis Consortium (CPTAC) dataset 32 (Figure S10E). This evidence concerns the gene MRC2 and neoplasm.